1/64
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
List the 6 general steps followed when treating a glaucoma pt
• Establish a diagnosis
• Establish baseline IOP, Fields, OCTs, and Photos
• Set a target IOP
• Initiate therapy to lower IOP to target
• Follow-up
• Reasses
Why is it so important to establish a specific dx when beginning to manage you glaucoma pt
different dx require different therapies and respond differently to certain therapies
if you are initiating a therapy and they are not responding well... that may be a sign of mis-dx
Give the 2 reasons why is it a key goal of glaucoma management to diagnosis glaucoma at an early, pre-symptomatic stage
- there is less response to therapy in a later stage disease
- there is increased risk of going blind despite good IOP control in later stages of the disease
List the 2 major challenges that clinicians managing glaucoma face
1. identifying subtle glaucoma
2. knowing when to treat vs when to watch
Boht missing a dx & treating unnecessarily are bad, but which one is generally worse
"failure to diagnose" is the most common lawsuit
(young/old) pt typically endure a more aggressive therapy plan, why
young
because they have more relative life span - therefore are more likely to go blind in their lifetime if they are not treated
Currently, _____ is the only known modifiable risk factorto delay the progression of glaucoma
IOP
List the 3 current tx options target IOP reduction to delay progressive glaucomatous damage and to delay onset of visual field loss
• Topical medications
• Laser trabeculoplasty
• Surgical drainage procedures
The Baltimore Eye Survey confirmed that while IOP was a major risk factor, _____% of the glaucoma patients had an IOP less than 21mmHg on diagnosis!
50%
(T/F) A certain IOP is equal to glaucomatous optic neuropathy
FALSE
If the pressure is too high for that INDIVIDUAL eye, then GON occurs
Define Target IOP
the upper limit of the range of measured IOP adequate to stop progressive pressure-induced injury of the ONH
OR
The highest IOP in a "given eye" which does not contribute to the development of clinically apparent glaucomatous optic nerve damage
(T/F) Target IOP can is periodically re-evaluated and revisited and may need to be changed as time goes on
TRUE
List the 4 most important factors to consider when picking target IOP for a pt
• Severity of glaucoma (ONH &VF)
• Baseline IOP
• Age
• Life expectancy
image slide 17
List 7 "other" risk factors to consider when picking target IOP for a pt
(excluding the 4 most important)
- severe damage in other eye
- fam hx of blindness from glaucoma
- high myopia
- ethnicity
- vascular risk factors
- rate of progression to date
- CCT
What is the general tx plan of a pt with early glaucoma/OHT diagnosed late inlife or with limited life expectancy
no tx required - observation
graph slide 18
What is the general tx plan of a pt with moderate glaucoma diagnosed at age of 50+
tx with meds and/or laser to lower IOP by 30%... may slow the rate of deterioration so that the patient never experiences visual problems
What is the general tx plan of a pt with advanced glaucoma and significant risk for functional loss
tx with meds and/or laser to lower IOP to the low teens... may slow the rate of deterioration so that the patient never experiences visual problems
What is the #1 most important factor when setting target IOP
severity of glauoma
What 2 things are assessed to determine the severity of glaucoma
- ONH evaluation
- VF loss
(essentially whichever one is worse is how the pt is classified)
(T/F) Visual field loss encroaching on fixation should prompt the physician to set a low target IOP regardless of baseline pressure
TRUE
this is nearing functional visual field loss
To establish a baseline IOP ideally, 24 hour diurnal curve could be created... however this is unpractical so the best estimate is to:
get 4-6 IOP readings at different times of day
There is a gradual, steady decrease in the number of nerve fibers in the ONH with age... about ___-___% decrease per decade after age 50 years
4-5%
(T/F) Older individuals may not need as aggressive lowering of IOP compared to younger individuals
TRUE
this is due to life expectancy
Pt with a low corneal hysteresis have a (low/high) response to tx and a (low/high) ruck of progressing
- high response to tx
- high risk of progressing
Give the range of CTT that is considered to be average
545-555 um
(anything lower = thin
anything higher = thick)
Give the name and findings of OHTS
Ocular Hypertension Treatment Study
findings:
20% reduction of IOP from baseline leads to a lower rate of glaucoma in OHT patients
Give the name and findings of LPGTS
Low Pressure Glaucoma Treatment Study
findings:
NTG patients treated with Brimonidine are LESS likely to have VF progression than those treated with Timolol
Possibly due to neuro-protective effects of Brimonidine
(did not use Latanoprost because this was an older study and Latanoprost was not commonly used at the time)
Give the name and findings of CIGTS
Collaborative Initial Glaucoma Treatment Study
findings:
found 35% reductions with meds and 48% reductions with surgery
but overall glaucoma progress will be minimal if patients are treated aggressively to achieve low target IOP regardless of tx method
Give the name and findings of EMGT
Early Manifest Glaucoma Trial
findings:
25% reduction in IOP reduced risk of progression by 50%
&
Every 1mm drop in IOP, reduces risk of progression by 10%
Give the name and findings of AGIS
Advanced Glaucoma Intervention Study
findings:
- pt w consistent IOP <18mmHg show almost no VF loss
- pt w 17.5mmHg or greater show significant worse VF loss when compared to pt w 14mmHg or less
- pt w consistent IOP <12.3mmHg show NO glaucoma progression
What is unique about the values presented int he AGIS study
they use a true mmHg measure and not a % of reduction
Give the name and findings of CNTGS
Collaborative Normal Tension Glaucoma Study
findings:
30% IOP reduction from baseline delayed progression of glaucoma
Which population of pt was studied in OHTS
OHTN
Which population of pt was studied in EMGT
POAG
Which population of pt was studied in CNTGS
NTG
Which population of pt was studied in CIGTS
newly dx POAG
Which population of pt was studied in AGIS
POAG not controlled w meds
Go learn the table of the studies on slide 26
ok fine
How is true baseline, or Tmax established through IOP
4-6 IOP readings, at least 2 in the morning and 1 to 2 in the late afternoon/evening
Peak (Tmax s meds) can be closely attained between which hours of the day..... there is a ___% likelihood of these readings being close to peak IOP
7:00 and 9:00am
75% chance
According to AAO recommendation for IOP-lowering in glaucoma and OHT..... we should aim for a ____% reductions in:
- mild damage pt
- advanced damage pt
- NTG pt
- OHT pt
- mild damage pt - 30%
- advanced damage pt - 40%
- NTG pt - 30%
- OHT pt - 20%
in POAG
According to the Guidelines of the European Glaucoma Society, what should be the target IOP of:
- early glaucoma pt
- moderate glaucoma pt
- advanced glaucoma pt
- terminal glaucoma pt
- early glaucoma pt: <18mmHg
- moderate glaucoma pt: <15mmHg
- advanced glaucoma pt: <12mmHg
- terminal glaucoma pt: <10mmHg
in NTG
According to the Guidelines of the European Glaucoma Society, what should be the target IOP of:
- early glaucoma pt
- moderate glaucoma pt
- advanced glaucoma pt
- early glaucoma pt: <15mmHg
- moderate glaucoma pt: <12mmHg
- advanced glaucoma pt: <10mmHg
What is the recommended target IOP Reductions Required to Reduce the Rate of POAG Related Damage in...
Ocular hypertensive patients who have risk factors such as ethnicity, vascular compromise, etc.
20%
What is the recommended target IOP Reductions Required to Reduce the Rate of POAG Related Damage in...
Early to moderate glaucoma patients who have been identified by field loss
30%
What is the recommended target IOP Reductions Required to Reduce the Rate of POAG Related Damage in...
Patients with moderate to severe glaucoma as identified by field loss and optic nerve head appearance
40-50%
(or near EVP)
(T/F) Having a target IOP documented as "as low as can possibly get it" is acceptable
TRUE
All glaucoma pt are seen at least every __________ even if they are at their target IOP and not progressing
6 months
All pt with POAG should be monitored closely for the first _________ to determine rate of progression
2 years
Progression despite achieving target IOP offers the clinician which 3 choices:
1) Are IOPs measured clinically an accurate reflection of IOP at other times? (compliance or diurnal)
2) Should we further lower the IOP medically?
3) Should we further lower the IOP surgically?
What is the limitations of using IOP measurements to determine a target IOP
numerous reasons for inaccurate tonometry
(if target IOP = 14 and you get a IOP = 16 reading, this is nor enough to immediate change the therapy.... this signifies the need to repeat tonometry on a subsequent visit)
What is the limitations of IOP fluctuations when it comes to target IOP
majority of patients with advanced glaucoma have IOP spikes away from office hours... so the Tmax used to determine a target may not be the true Tmax of that pt
What is the limitations of setting a very low target IOP
Benefit to setting the target <10mmHg is questionable... usually IOPs this low require surgery and with surgery comes risks so need to ensure the benefit is worth the risk for that pt
(T/F) Reaching a target IOP signifies contorl of the disease process
FALSE
target does not equal control
test results and lack of strucutural and functional changes equal control
just becuase a pt is at the target IOP that you once set for them does not mean they are under control they must continue to be monitored until lack of progression is evident
List 6 considerations that should be made to acheive successful glaucoma management
- target IOP
- side effects/contraindications
- cost and availability
- ease of instillation
- compliance issues
- pt understanding
(T/F) All instructions to pt should be given both verbally and written
TRUE
it is essential to communicate well to the pt and ensure they understand the goals, potential adverse effects, what they should report back to you or any troubles they may have
A dilated-pupil fundus examination and perimetry should be performed at least __________ year for all glaucoma pt
one time per year
Every patient diagnosed with glaucoma should be seen at least every ______
6 months
Time interval of f/u depends on which 3 characteristics
- IOP level
- disease stage
- stability
What is the recommended frequency of follow up for OHT pt
every 3 - 6 months
depending on the duration of IOP control
What is the recommended frequency of follow up for pt with stable mild-stage disease
every 3 - 6 months
depending on the duration of IOP control
What is the recommended frequency of follow up for pt with stable moderate-stage disease
every 2 - 4 months
depending on the duration of stability and the IOP
What is the recommended frequency of follow up for pt with stable severe disease
every 1 - 3 months
depending on the duration of stability and the IOP
What is the recommended frequency of follow up for pt with recently established stability
every 1 - 3 months
depending on the severity and the IOP
What is the recommended frequency of follow up for pt with unstable disease
cases in which IOP, ON, or VF is unstable require adjustment of therapy, which could involve weekly or biweekly follow-up for a brief period or until stability is achieved